Related Experiment Video
Updated: May 9, 2025

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
Cell-Based Therapeutic Strategies for Autoimmune Diseases
Francisco B Quero1, Tays Troncoso-Bravo1, Mónica A Farías1
1Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
Cell-based therapies offer a promising new avenue for treating autoimmune diseases by leveraging various cell types. This review explores their mechanisms, potential benefits, and challenges for patient safety and production.
Area of Science:
- Immunology
- Regenerative Medicine
- Cell Therapy
Background:
- Autoimmune disorder management faces challenges in safety, efficiency, and specificity.
- Cell-based therapeutic strategies are emerging as a novel treatment approach.
Purpose of the Study:
- To discuss various cell therapy platforms for autoimmune diseases.
- To explore their immunological mechanisms, therapeutic potential, and benefits.
- To address challenges in production, scaling, risks, and patient safety.
Main Methods:
- Review of existing literature on cell therapy platforms.
- Analysis of immunological mechanisms of action.
- Evaluation of therapeutic potential and clinical benefits.
- Identification of challenges in cell therapy implementation.
Main Results:
- Multiple cell therapy platforms exist, including tolerogenic dendritic cells, regulatory T cells, CAR-T cells, and stem cells.
- Each platform possesses unique biological features and immunological mechanisms.
- Cell therapies show significant therapeutic potential for autoimmune diseases.
Conclusions:
- Cell-based therapies present a promising frontier for autoimmune disease treatment.
- Addressing challenges in production, scalability, safety, and risk management is crucial for clinical translation.
- Further research is needed to optimize these therapies for widespread patient benefit.
More Related Videos
11:31High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
08:12Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014
Related Concept Videos
Tumor Immunotherapy
Cell-mediated Immune Responses
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
iPS Cell Differentiation
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
EPS and iPS Cells in Disease Research